{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:27:38Z","timestamp":1794536858339,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["RS-2023-00274176"],"award-info":[{"award-number":["RS-2023-00274176"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31289-3","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T18:25:30Z","timestamp":1765045530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Time-updated FIB-4 index predicts coronary artery calcification progression in individuals with metabolic dysfunction\u2013associated steatotic liver disease"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-492X","authenticated-orcid":false,"given":"Yesung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8535-3988","authenticated-orcid":false,"given":"Woncheol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"31289_CR1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Sanyal, A. J. & George, J. M. A. F. L. D. MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158, 1999\u20132014. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312 (2020).","journal-title":"Gastroenterology"},{"key":"31289_CR2","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ajg.2016.178","volume":"111","author":"Y Chang","year":"2016","unstructured":"Chang, Y. et al. Metabolically healthy obesity and the development of nonalcoholic fatty liver disease. Am. J. Gastroenterol. 111, 1133\u20131140. https:\/\/doi.org\/10.1038\/ajg.2016.178 (2016).","journal-title":"Am. J. Gastroenterol."},{"key":"31289_CR3","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams, L. A., Anstee, Q. M., Tilg, H. & Targher, G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 66, 1138\u20131153. https:\/\/doi.org\/10.1136\/gutjnl-2017-313884 (2017).","journal-title":"Gut"},{"key":"31289_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384. https:\/\/doi.org\/10.1002\/hep.28431 (2016).","journal-title":"Hepatology"},{"key":"31289_CR5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and Pharmacological implications. Gut 69, 1691\u20131705. https:\/\/doi.org\/10.1136\/gutjnl-2020-320622 (2020).","journal-title":"Gut"},{"key":"31289_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah, A. G., Lydecker, A. & Murray, K. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 7, 1104\u20131112. https:\/\/doi.org\/10.1016\/j.cgh.2009.05.033 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"31289_CR7","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo, P., Kleiner, D. E. & Dam-Larsen, S. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149, 389\u2013397e310. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.043 (2015).","journal-title":"Gastroenterology"},{"key":"31289_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jacc.2006.10.079","volume":"49","author":"MJ Budoff","year":"2007","unstructured":"Budoff, M. J., Shaw, L. J. & Liu, S. T. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J. Am. Coll. Cardiol. 49, 186\u2013192. https:\/\/doi.org\/10.1016\/j.jacc.2006.10.079 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"31289_CR9","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1177\/2047487319830485","volume":"26","author":"P Faggiano","year":"2019","unstructured":"Faggiano, P. et al. Cardiac calcification as a marker of subclinical atherosclerosis and predictor of cardiovascular events: A review of the evidence. Eur. J. Prev. Cardiol. 26, 1191\u20131204. https:\/\/doi.org\/10.1177\/2047487319830485 (2019).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"31289_CR10","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1056\/NEJMoa072100","volume":"358","author":"R Detrano","year":"2008","unstructured":"Detrano, R. et al. Coronary calcium as a predictor of coronary events in four Racial or ethnic groups. N Engl. J. Med. 358, 1336\u20131345. https:\/\/doi.org\/10.1056\/NEJMoa072100 (2008).","journal-title":"N Engl. J. Med."},{"key":"31289_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)31561-0","volume":"396","author":"F Mauvais-Jarvis","year":"2020","unstructured":"Mauvais-Jarvis, F. et al. Sex and gender: modifiers of health, disease, and medicine. Lancet 396, 565\u2013582. https:\/\/doi.org\/10.1016\/S0140-6736(20)31561-0 (2020).","journal-title":"Lancet"},{"key":"31289_CR12","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1111\/dom.16568","volume":"27","author":"M Jamalinia","year":"2025","unstructured":"Jamalinia, M., Zare, F., Mantovani, A., Targher, G. & Lonardo, A. Metabolic dysfunction-associated steatotic liver disease and sex-specific risk of fatal and non-fatal cardiovascular events: A meta-analysis. Diabetes Obes. Metab. 27, 5171\u20135181. https:\/\/doi.org\/10.1111\/dom.16568 (2025).","journal-title":"Diabetes Obes. Metab."},{"key":"31289_CR13","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.2147\/DMSO.S426102","volume":"16","author":"C Lu","year":"2023","unstructured":"Lu, C., Chen, Y., Zhang, Y. & Zhao, X. Liver fibrosis scores and coronary artery disease: novel findings in patients with metabolic Dysfunction-Associated fatty liver disease. Diabetes Metab. Syndr. Obes. 16, 2627\u20132637. https:\/\/doi.org\/10.2147\/DMSO.S426102 (2023).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"31289_CR14","doi-asserted-by":"publisher","first-page":"100780","DOI":"10.1016\/j.lanepe.2023.100780","volume":"36","author":"QM Anstee","year":"2024","unstructured":"Anstee, Q. M. et al. Prognostic utility of Fibrosis-4 index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and\/or type 2 diabetes: a longitudinal cohort study. Lancet Reg. Health Eur. 36, 100780. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100780 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"31289_CR15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21168","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K., Lissen, E. & Clumeck, N. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325. https:\/\/doi.org\/10.1002\/hep.21168 (2006).","journal-title":"Hepatology"},{"key":"31289_CR16","doi-asserted-by":"publisher","first-page":"18323","DOI":"10.1038\/s41598-020-75266-4","volume":"10","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease. Sci. Rep. 10, 18323. https:\/\/doi.org\/10.1038\/s41598-020-75266-4 (2020).","journal-title":"Sci. Rep."},{"key":"31289_CR17","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","volume":"161","author":"F Kanwal","year":"2021","unstructured":"Kanwal, F. et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology 161, 1657\u20131669. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.049 (2021).","journal-title":"Gastroenterology"},{"key":"31289_CR18","doi-asserted-by":"publisher","first-page":"e035371","DOI":"10.1161\/JAHA.123.035371","volume":"13","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Association between noninvasive liver fibrosis scores and heart failure in a general population. J. Am. Heart Assoc. 13, e035371. https:\/\/doi.org\/10.1161\/JAHA.123.035371 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"31289_CR19","doi-asserted-by":"publisher","first-page":"101153","DOI":"10.1016\/j.lanepe.2024.101153","volume":"48","author":"J Boeckmans","year":"2025","unstructured":"Boeckmans, J. et al. Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort study. Lancet Reg. Health Eur. 48, 101153. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101153 (2025).","journal-title":"Lancet Reg. Health Eur."},{"key":"31289_CR20","doi-asserted-by":"publisher","first-page":"3529149","DOI":"10.1155\/2016\/3529149","volume":"2016","author":"ML Contreras-Zentella","year":"2016","unstructured":"Contreras-Zentella, M. L. & Hernandez-Munoz, R. Is Liver Enzyme Release Really Associated with Cell Necrosis Induced by Oxidant Stress?. Oxid. Med. Cell Longev. 2016, 3529149. https:\/\/doi.org\/10.1155\/2016\/3529149 (2016).","journal-title":"Oxid. Med. Cell Longev."},{"key":"31289_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/life11010039","author":"A Gasecka","year":"2021","unstructured":"Gasecka, A., Rogula, S., Szarpak, L. & Filipiak, K. J. LDL-cholesterol and platelets: insights into their interactions in atherosclerosis. Life (Basel) https:\/\/doi.org\/10.3390\/life11010039 (2021).","journal-title":"Life (Basel)"},{"key":"31289_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/HMER.S74612","volume":"8","author":"O Mitchell","year":"2016","unstructured":"Mitchell, O., Feldman, D. M., Diakow, M. & Sigal, S. H. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat. Med. 8, 39\u201350. https:\/\/doi.org\/10.2147\/HMER.S74612 (2016).","journal-title":"Hepat. Med."},{"key":"31289_CR23","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/nu5051544","volume":"5","author":"M Gaggini","year":"2013","unstructured":"Gaggini, M. et al. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 5, 1544\u20131560. https:\/\/doi.org\/10.3390\/nu5051544 (2013).","journal-title":"Nutrients"},{"key":"31289_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/apt.17617","volume":"58","author":"M Jamalinia","year":"2023","unstructured":"Jamalinia, M., Zare, F. & Lankarani, K. B. Systematic review and meta-analysis: association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 58, 384\u2013394. https:\/\/doi.org\/10.1111\/apt.17617 (2023).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"31289_CR25","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.ultrasmedbio.2025.05.020","volume":"51","author":"R Cannella","year":"2025","unstructured":"Cannella, R. et al. Performance of ultrasound liver fat quantification for the assessment of hepatic steatosis using MRI fat fraction as a reference standard. Ultrasound Med. Biol. 51, 1495\u20131502. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2025.05.020 (2025).","journal-title":"Ultrasound Med. Biol."},{"key":"31289_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1373\/clinchem.2006.081257","volume":"53","author":"Y Chang","year":"2007","unstructured":"Chang, Y., Ryu, S., Sung, E. & Jang, Y. Higher concentrations of Alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. Clin. Chem. 53, 686\u2013692. https:\/\/doi.org\/10.1373\/clinchem.2006.081257 (2007).","journal-title":"Clin. Chem."},{"key":"31289_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/s1590-8658(02)80111-6","volume":"34","author":"UL Mathiesen","year":"2002","unstructured":"Mathiesen, U. L. et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild\/moderate abnormalities of liver transaminases. Dig. Liver Dis. 34, 516\u2013522. https:\/\/doi.org\/10.1016\/s1590-8658(02)80111-6 (2002).","journal-title":"Dig. Liver Dis."},{"key":"31289_CR28","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.jhep.2014.11.041","volume":"62","author":"S Ryu","year":"2015","unstructured":"Ryu, S. et al. Age at menarche and non-alcoholic fatty liver disease. J. Hepatol. 62, 1164\u20131170. https:\/\/doi.org\/10.1016\/j.jhep.2014.11.041 (2015).","journal-title":"J. Hepatol."},{"key":"31289_CR29","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the, L., European Association for the Study of, D. & European Association for the Study of, O. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol. 81 492\u2013542 https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031 (2024).","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"31289_CR30","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.3350\/cmh.2025.0045","volume":"31","author":"W Sohn","year":"2025","unstructured":"Sohn, W. et al. KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025. Clin. Mol. Hepatol. 31, S1\u2013S31. https:\/\/doi.org\/10.3350\/cmh.2025.0045 (2025).","journal-title":"Clin. Mol. Hepatol."},{"key":"31289_CR31","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77, 1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323 (2023).","journal-title":"Hepatology"},{"key":"31289_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-t","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston, A. S. et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15, 827\u2013832. https:\/\/doi.org\/10.1016\/0735-1097(90)90282-t (1990).","journal-title":"J. Am. Coll. Cardiol."},{"key":"31289_CR33","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1016\/j.jacc.2014.03.042","volume":"63","author":"Y Chang","year":"2014","unstructured":"Chang, Y. et al. Metabolically-healthy obesity and coronary artery calcification. J. Am. Coll. Cardiol. 63, 2679\u20132686. https:\/\/doi.org\/10.1016\/j.jacc.2014.03.042 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"31289_CR34","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jcmg.2010.08.018","volume":"3","author":"MJ Budoff","year":"2010","unstructured":"Budoff, M. J. et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc. Imaging. 3, 1229\u20131236. https:\/\/doi.org\/10.1016\/j.jcmg.2010.08.018 (2010).","journal-title":"JACC Cardiovasc. Imaging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31289-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31289-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31289-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T18:03:20Z","timestamp":1768327400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31289-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31289"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31289-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Kangbuk Samsung Hospital (IRB No: KBSMC2025-06-031). The requirement for informed consent was waived because only de-identified data routinely collected during health screening examinations were used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"1459"}}